Cargando…

Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma

BACKGROUND: Second head and neck neuroendocrine carcinoma (NEC) after radical radiotherapy for nasopharyngeal carcinoma (NPC) treatment is rarely reported. The prognosis of second cancer is poor, and our research focuses on finding a breakthrough in the treatment. In this study, we aimed to investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Ying-peng, Liu, Qiao-dan, Lin, Yu-jing, Peng, Shun-li, Wang, Rong, Xu, Xi-wei, Wei, Wei, Zhong, Gui-hua, Zhou, Yu-ling, Zhang, Ya-qin, Liu, Ye, Wang, Si-yang, Hong, Hai-yu, Liu, Zhi-gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504105/ https://www.ncbi.nlm.nih.gov/pubmed/34635145 http://dx.doi.org/10.1186/s13014-021-01898-z

Ejemplares similares

Prognostic Factors and Survival in Patients with Radiation-Related Second Malignant Neoplasms Following Radiotherapy for Nasopharyngeal Carcinoma
por: Xi, Mian, et al.
Publicado: (2013)

Radiomics for Diagnosis and Radiotherapy of Nasopharyngeal Carcinoma
por: Zhang, Yu-mei, et al.
Publicado: (2022)

Efficacy and Safety of Chemotherapy Combined with Stereotactic Radiotherapy in the Treatment of Nasopharyngeal Carcinoma
por: Shan, Guo-Ping, et al.
Publicado: (2017)

Secondary Nasopharyngeal Mixed Adenoneuroendocrine Carcinoma After Radical Radiotherapy for Nasopharyngeal Carcinoma: A Rare Case and Literature Review
por: Huang, Donglan, et al.
Publicado: (2021)

Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology
por: Wang, Ya-Qin, et al.
Publicado: (2020)

A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma
por: Qiu, Wen-Ze, et al.
Publicado: (2017)

Etiology and management of nasopharyngeal hemorrhage after radiotherapy for nasopharyngeal carcinoma
por: Zhan, Jiabin, et al.
Publicado: (2019)

Hopkins criteria for residual disease assessment after definitive radiotherapy in nasopharyngeal carcinoma
por: Liu, Yang, et al.
Publicado: (2019)

Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis
por: Zhong, Guihua, et al.
Publicado: (2022)

Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
por: He, Yan, et al.
Publicado: (2018)

Secondary Nasopharyngeal Mixed Adenoneuroendocrine Carcinoma After Radical Radiotherapy for Nasopharyngeal Carcinoma: A Rare Case and Literature Review [Corrigendum]
Publicado: (2022)

Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma
por: Liao, Lie-Qiang, et al.
Publicado: (2016)

Neoantigen landscape in metastatic nasopharyngeal carcinoma
por: Lin, Mei, et al.
Publicado: (2021)

Clinicopathologic characteristics of second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Wang, Xi, et al.
Publicado: (2023)

Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma
por: Dong, Dan-Ning, et al.
Publicado: (2021)

The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma
por: Peng, Liang, et al.
Publicado: (2019)

Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis
por: Wang, Lin, et al.
Publicado: (2022)

Clinical application of parathyroid autotransplantation in endoscopic radical resection of thyroid carcinoma
por: Zhang, Qi, et al.
Publicado: (2022)

A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy
por: Qiu, Wen-Ze, et al.
Publicado: (2017)

Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Xue, Fen, et al.
Publicado: (2022)

Osthole sensitizes with radiotherapy to suppress tumorigenesis of human nasopharyngeal carcinoma in vitro and in vivo
por: Peng, Lin, et al.
Publicado: (2018)

N6-Methyladenosine RNA Modification Landscape in the Occurrence and Recurrence of Nasopharyngeal Carcinoma
por: Wang, Yu Min, et al.
Publicado: (2022)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
por: Li, Hongjia, et al.
Publicado: (2022)

The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma
por: Zhu, Xiao-Xia, et al.
Publicado: (2017)

A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Peng, Liang, et al.
Publicado: (2020)

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma
por: Peng, Pei-Jian, et al.
Publicado: (2015)

A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma
por: Chen, Jing, et al.
Publicado: (2018)

Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy
por: Chang, Hui, et al.
Publicado: (2019)

Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Wu, Shixiu, et al.
Publicado: (2015)

Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma
por: Jia, Guo-Dong, et al.
Publicado: (2023)

Bacterial brain abscess in patients with nasopharyngeal carcinoma following radiotherapy: microbiology, clinical features and therapeutic outcomes
por: Fang, Peng-Hsiang, et al.
Publicado: (2012)

Favorable prognosis of female patients with nasopharyngeal carcinoma
por: Lu, Xing, et al.
Publicado: (2013)

Author Correction: Clinicopathologic characteristics of second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Wang, Xi, et al.
Publicado: (2023)

Impairment mechanism of nasal mucosa after radiotherapy for nasopharyngeal carcinoma
por: Fang, Caishan, et al.
Publicado: (2022)

Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma
por: Feng, Mei, et al.
Publicado: (2018)

Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma
por: Zong, Jing-Feng, et al.
Publicado: (2021)

A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy
por: Li, Minying, et al.
Publicado: (2022)

MRI-Only Radiotherapy Planning for Nasopharyngeal Carcinoma Using Deep Learning
por: Ma, Xiangyu, et al.
Publicado: (2021)

Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution
por: Liu, Yang, et al.
Publicado: (2021)

Current Radiotherapy Considerations for Nasopharyngeal Carcinoma †
por: Ng, Wai Tong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ue8gkfefhc1o22jvetgshqvs6